Market Cap
13972903936.00
INCY
Incyte Corporation
Exchange: nyse
Multiples
- P/E: 805.89
- P/BV: 4.41
- P/TBV: 2.78
Description:
Incyte Corporation (INCY) is a biopharmaceutical company listed on the New York Stock Exchange (NYSE). The company focuses on the discovery, development, and commercialization of innovative therapies to address unmet medical needs in oncology and inflammation/inflammatory diseases. Incyte has built its reputation by bringing forward several drugs that target specific genetic mutations associated with various cancers, aiming to improve patient outcomes through precision medicine.
Data:
Yields:
Earnings Yield
-0.046307607412
Return on Capital
0.019748225070
CAGR (net income)
-70.7%
CAGR Length
2.75
Dividend Rate
